| Dr Jacob Joseph Parker, MD | |
|
921 Ne 13th St, Oklahoma City, OK 73104-5007 | |
| (405) 456-5353 | |
| (405) 456-1555 |
| Full Name | Dr Jacob Joseph Parker |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 921 Ne 13th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093788770 | NPI | - | NPPES |
| P00403538 | Other | MO | MEDICARE RAILROAD |
| 204448104 | Medicaid | MO | |
| 163960001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | G8697 (California) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 25453 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jacob Joseph Parker, MD 921 Ne 13th St, Oklahoma City, OK 73104-5007 Ph: (405) 456-5353 | Dr Jacob Joseph Parker, MD 921 Ne 13th St, Oklahoma City, OK 73104-5007 Ph: (405) 456-5353 |
News Archive
Studies of human tumor cells implanted in mice have shown that the abnormal activation of four genes drives the spread of breast cancer to the lungs.
Although cystic fibrosis patients in clinical trials had more severe illness, worse lung function, a lower weight level and more respiratory infection than non-participants, their involvement in research studies resulted in less lung function decline over a 7-year period.
A study from the Thoracic Oncology Research Group (TORG), Division of Pulmonary and Critical Care, Medical University of South Carolina, aimed to examine the adherence to annual low-dose computed tomography (LDCT) screening after baseline LDCT within the Veteran Health Administration Lung Cancer Screening Demonstration Project (LCDSDP).
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it will debut its evolutionary MRI software suite at the Radiological Society of North America (RSNA) annual meeting at McCormick Place in Chicago on November 29th - December 4th.
Oncolytics Biotech Inc. announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer.
› Verified 2 days ago
Dr. Jennifer Kathleen Hinkle, MD Radiology Medicare: Medicare Enrolled Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-456-2589 | |
Dr. Bryan Lee Vanzandt, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4625 S Western Ave, Oklahoma City, OK 73109 Phone: 405-632-2323 Fax: 405-631-9315 | |
Charles Eric Eckman, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 14101 Parkway Commons, Oklahoma City, OK 73134 Phone: 405-749-6277 | |
Robert K Gelczer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St., Suite C-40, Oklahoma City, OK 73112 Phone: 405-945-4741 Fax: 888-972-5320 | |
Vikas Vij, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Suite C-40, Oklahoma City, OK 73112 Phone: 405-945-4741 Fax: 888-972-5320 | |
William G Phillips, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2224 Nw 50th St, Suite 276w, Oklahoma City, OK 73112 Phone: 405-858-2350 | |
Ronald Ray Magee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5224 E I 240 Service Rd Ste 303, Oklahoma City, OK 73135 Phone: 405-608-3800 Fax: 405-628-6477 |